INS and obesity disorder: DM is a markedly heterogeneous disease, and an emerging paradigm in the non-oncology population is the identification of groups or clusters of individuals with phenotypically distinct DM (e.g., insulin-resistant, insulin-deficient, age-related, and obesity-related) (86, 87).